RE:AssessmentI have the same ones plus AYR and InMed Pharma. Was watching a YouTube video (Market Minute I think) where the analyst was saying Green Thumb was down due to valuation and regulatory headwinds. The list of you have is fantastic. Brokers make money when you trade so you must decide whether you are trader or an investor. I decided to be the latter. The big wealth comes with time and most people don't have the patience. We know the big MSO uplisting will happen at some point and full legalization is likely in 2026 (same for Europe). By then, NY and NJ will be maturing markets and names like Cura and GTII will have sky high revenues. Further, for InMed I'm convinced they at the frontier for a whole new class of pharma grade cannabinoids compounds to supply Big Pharma but it might take 3-10 years for this to happen. Maybe trading ok when this are on OTC but I would buy them at a good price and hold for 5-10 years - then retire :-) Just rewind 5 years to 2016 and see where we were then. Trulieve was just starting! Now, imagine where we will be in 5 years. Patience is key.